OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-10-2621
Authors: Richard Quek, Qian Wang, Jeffrey A. Morgan, Geoffrey I. Shapiro, James E. Butrynski, Nikhil Ramaiya, Tarsha Huftalen, Nicole Jederlinic, Judith Manola, Andrew J. Wagner, George D. Demetri, Suzanne George
Institution: Dana-Farber Cancer Institute
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: everolimus, figitumumab, mTOR inhibition, IGF1R inhibition, combination therapy, advanced sarcoma, solid tumors, dose-limiting toxicity, recommended phase 2 dose, pharmacokinetic interactions, mucositis, monoclonal antibodies, mTOR inhibitors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2104878828
FWCI: 7.6
Cites: 40
Cited by: 167
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms